| Issue Date | Title | Author(s) |
| 22-Nov-2016 | Bridging the gap between clinicians and systems biologists: From network biology to translational biomedical research | Natini Jinawath; Sacarin Bunbanjerdsuk; Maneerat Chayanupatkul; Nuttapong Ngamphaiboon; Nithi Asavapanumas; Jisnuson Svasti; Varodom Charoensawan; Mahidol University; Chulalongkorn University; Baylor College of Medicine; Chulabhorn Research Institute |
| 1-Feb-2019 | Characteristics and impact of programmed death-ligand 1 expression, CD8+ tumor-infiltrating lymphocytes, and p16 status in head and neck squamous cell carcinoma | Nuttapong Ngamphaiboon; Teeranuch Chureemas; Teerada Siripoon; Lalida Arsa; Narumol Trachu; Chuleeporn Jiarpinitnun; Poompis Pattaranutaporn; Ekaphop Sirachainan; Noppadol Larbcharoensub; Faculty of Medicine, Ramathibodi Hospital, Mahidol University |
| 1-Dec-2018 | Characterization of PD-L1 and PD-1 Expression and CD8+ Tumor-infiltrating Lymphocyte in Epstein-Barr Virus-associated Nasopharyngeal Carcinoma | Noppadol Larbcharoensub; Komkrit Mahaprom; Chuleeporn Jiarpinitnun; Narumol Trachu; Nattha Tubthong; Poompis Pattaranutaporn; Ekaphop Sirachainan; Nuttapong Ngamphaiboon; Faculty of Medicine, Ramathibodi Hospital, Mahidol University; Division of Medical Oncology; Division of Radiation Oncology |
| 15-Aug-2018 | Emergence of intrahepatic cholangiocarcinoma: How high-throughput technologies expedite the solutions for a rare cancer type | Meng Shin Shiao; Khajeelak Chiablaem; Varodom Charoensawan; Nuttapong Ngamphaiboon; Natini Jinawath; Faculty of Medicine, Ramathibodi Hospital, Mahidol University; Mahidol University |
| 1-Jan-2015 | Hospice utilization and end-of-life care in metastatic breast cancer patients at a comprehensive cancer center | Tracey L. O'Connor; Nuttapong Ngamphaiboon; Adrienne Groman; Debra L. Luczkiewicz; Sarah M. Kuszczak; Pei C. Grant; Christopher W. Kerr; Roswell Park Cancer Institute; Mahidol University; Center for Hospice and Palliative Care; Michael E. DeBakey VA Medical Center |
| 15-Sep-2019 | Multi-Targeted Tyrosine Kinase Inhibitor-Induced Hyperammonemic Encephalopathy: a Report of Two Cases Using Pazopanib, Sunitinib, and Regorafenib | Noppadon Kongsuphon; Maturos Soukavanitch; Noramon Teeraaumpornpunt; Jitprapa Konmun; Touch Ativitavas; Nuttapong Ngamphaiboon; Faculty of Medicine, Ramathibodi Hospital, Mahidol University |
| 1-Jul-2019 | Oncoproteomic and gene expression analyses identify prognostic biomarkers for second primary malignancy in patients with head and neck squamous cell carcinoma | Sacarin Bunbanjerdsuk; Nutchavadee Vorasan; Thammakorn Saethang; Tanjitti Pongrujikorn; Duangjai Pangpunyakulchai; Narongsak Mongkonsiri; Lalida Arsa; Nintita Thokanit; Warut Pongsapich; Tauangtham Anekpuritanang; Nuttapong Ngamphaiboon; Artit Jinawath; Somkiat Sunpaweravong; Trairak Pisitkun; Bhoom Suktitipat; Natini Jinawath; Chulalongkorn University; Faculty of Medicine, Prince of Songkia University; Faculty of Medicine, Ramathibodi Hospital, Mahidol University; Thailand Ministry of Public Health; Mahidol University; Faculty of Medicine, Siriraj Hospital, Mahidol University |
| 23-Nov-2019 | Pembrolizumab alone or with chemotherapy versus cetuximab with chemotherapy for recurrent or metastatic squamous cell carcinoma of the head and neck (KEYNOTE-048): a randomised, open-label, phase 3 study | Barbara Burtness; Kevin J. Harrington; Richard Greil; Denis Soulières; Makoto Tahara; Gilberto de Castro; Amanda Psyrri; Neus Basté; Prakash Neupane; Åse Bratland; Thorsten Fuereder; Brett G.M. Hughes; Ricard Mesía; Nuttapong Ngamphaiboon; Tamara Rordorf; Wan Zamaniah Wan Ishak; Ruey Long Hong; René González Mendoza; Ananya Roy; Yayan Zhang; Burak Gumuscu; Jonathan D. Cheng; Fan Jin; Danny Rischin; Guillermo Lerzo; Marcelo Tatangelo; Mirta Varela; Juan Jose Zarba; Michael Boyer; Hui Gan; Bo Gao; Brett Hughes; Girish Mallesara; Anne Taylor; Martin Burian; Carlos Henrique Barrios; Dalvaro Oliveira de Castro Junior; Gilberto Castro; Fabio Andre Franke; Gustavo Girotto; Iane Pinto Figueiredo Lima; Ulisses Ribaldo Nicolau; Gustavo Dix Junqueira Pinto; Lucas Santos; Ana Paula Victorino; Neil Chua; Felix Couture; Richard Gregg; Aaron Hansen; John Hilton; Joy McCarthy; Denis Soulieres; Rodrigo Ascui; Pablo Gonzalez; Luis Villanueva; Marco Torregroza; Angela Zambrano; Petra Holeckova; Zdenek Kral; Bohuslav Melichar; Jana Prausova; Milan Vosmik; Maria Andersen; Niels Gyldenkerne; Hannes Jurgens; Kadri Putnik; Petri Reinikainen; Viktor Gruenwald; Simon Laban; Gerasimos Aravantinos; Ioannis Boukovinas; Vassilis Georgoulias; Dora Kwong; Yousuf Al-Farhat; Tibor Csoszi; Jozsef Erfan; Geza Horvai; Laszlo Landherr; Eva Remenar; Agnes Ruzsa; Judit Szota; Salem Billan; Iris Gluck; Orit Gutfeld; Aron Popovtzer; Marco Benasso; Simona Bui; Vittorio Ferrari; Lisa Licitra; Franco Nole; Takashi Fujii; Yasushi Fujimoto; Nobuhiro Hanai; Hiroki Hara; Koji Matsumoto; Kenji Mitsugi; Nobuya Monden; Masahiro Nakayama; Kenji Okami; Nobuhiko Oridate; Oslo University Hospital; National Taiwan University Hospital; Peter Maccallum Cancer Centre; University of Malaya; Royal Brisbane and Women's Hospital; University of Melbourne; UniversitatsSpital Zurich; Yale School of Medicine; Royal Marsden NHS Foundation Trust; Faculty of Medicine, Ramathibodi Hospital, Mahidol University; Attikon University Hospital; Paracelsus Medizinische Privatuniversitat; Hospital Universitari Vall d'Hebron; Hospital Universitari de Bellvitge; Medizinische Universitat Wien; National Cancer Center Hospital East; Centre Hospitalier de L'Universite de Montreal; Merck & Co., Inc.; University of Kansas Medical Center; Cancer Cluster Salzburg; Instituto do Câncer do Estado de São Paulo; Unidad de Investigación en Salud de |
| 1-Jan-2015 | A phase i study of the histone deacetylase (HDAC) inhibitor entinostat, in combination with sorafenib in patients with advanced solid tumors | Nuttapong Ngamphaiboon; Grace K. Dy; Wen Wee Ma; Yujie Zhao; Thanyanan Reungwetwattana; Dawn Depaolo; Yi Ding; William Brady; Gerald Fetterly; Alex A. Adjei; Roswell Park Cancer Institute; Mahidol University |
| 1-Jan-2014 | Safety and tolerability of docetaxel, cyclophosphamide, and trastuzumab compared to standard trastuzumab-based chemotherapy regimens for early-stage human epidermal growth factor receptor 2-positive breast cancer | Potjana Jitawatanarat; Tracey L. O’connor; Ellen B. Kossoff; Ellis G. Levine; Kaweesak Chittawatanarat; Nuttapong Ngamphaiboon; Roswell Park Cancer Institute; Chiang Mai University; Mahidol University |
| 1-Sep-2017 | Tolerability and efficacy of concurrent chemoradiotherapy comparing carboplatin/paclitaxel versus platinum/5-FU regimen for locally advanced esophageal and esophagogastric junction cancers | Amorn Tamtai; Chuleeporn Jiarpinitnun; Pitichote Hiranyatheb; Nattawut Unwanatham; Eakapop Sirachainun; Chairat Supsamutchai; Poompis Pattaranutaporn; Nuttapong Ngamphaiboon; Mahidol University |
